Gufic BioSciences announced that the Board of Directors of the Company at its meeting held on 4 June 2021, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 158.95% to Rs 12.87 crore in the quarter ended March 2021 as against Rs 4.97 crore during the previous quarter ended March 2020. Sales rose 51.52% to Rs 131.93 crore in the quarter ended March 2021 as against Rs 87.07 crore during the previous quarter ended March 2020.

For the full year,net profit rose 94.93% to Rs 44.23 crore in the year ended March 2021 as against Rs 22.69 crore during the previous year ended March 2020. Sales rose 28.74% to Rs 487.70 crore in the year ended March 2021 as against Rs 378.84 crore during the previous year ended March 2020.

Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 4 June 2021..

Powered by Capital Market - Live News

The Board of Gufic BioSciences will hold a board meeting on 04 June 2021 to approve the allotment of 1,91,14,506 Equity Shares of Re. 1/-earh to the shareholders of Gufic Lifesciences (Transferor Company) pursuant to the order passed by Hon'ble National Company Law Tribunal (NCLT) Ahmedabad bench dated 31 December 2020 and NCLT Mumbai bench dated 11 March 2021, sanctioning the Scheme of Amalgamation of the Transferor Company with Gufic Biosciences and their respective shareholders and creditors

Powered by Capital Market - Live News